Pancreatic Cancer Research

ResearcherSoochow UniversityNo recent work listed

Bingkai Xiao

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5053105144. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. SETD8 inhibits ferroptosis in pancreatic cancer by inhibiting the expression of RRAD. Co-author DOI 10.1186/s12935-023-02899-6↗
  2. A positive feedback loop of ARF6 activates ERK1/2 signaling pathway via DUSP6 silencing to promote pancreatic cancer progression. Co-author DOI 10.3724/abbs.2022111↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zekun Lu · 2 shared papers, 2022–2023 · strength 0.31
  2. Xiaowu Xu · 2 shared papers, 2022–2023 · strength 0.31
  3. Qiangsheng Hu · 1 shared paper, 2023 · strength 0.17
  4. Xuemin Chen · 1 shared paper, 2023 · strength 0.17
  5. Shunrong Ji · 1 shared paper, 2023 · strength 0.17
  6. Yi Qin · 1 shared paper, 2023 · strength 0.17
  7. Xuemin Chen · 1 shared paper, 2022 · strength 0.15
  8. Yue Zhang · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.